SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-081729
Filing Date
2013-11-06
Accepted
2013-11-06 16:34:46
Documents
6
Period of Report
2013-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-23684_18k.htm 8-K 39766
2 EX-4.1 a13-23684_1ex4d1.htm EX-4.1 103771
3 EX-10.1 a13-23684_1ex10d1.htm EX-10.1 1014566
4 EX-10.2 a13-23684_1ex10d2.htm EX-10.2 547717
5 EX-99.1 a13-23684_1ex99d1.htm EX-99.1 15131
6 GRAPHIC g236841mmi001.gif GRAPHIC 3660
  Complete submission text file 0001104659-13-081729.txt   1727431
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 131196908
SIC: 2834 Pharmaceutical Preparations